Polaris Group (TPE:6550) ROC %: -46.75% (As of Dec. 2025)


TPE:6550 Polaris Group TPE:6550
59 GF Score
Price NT$13.05
GF Value NT$55.10
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Polaris Group ROC %?

Polaris Group TPE:6550 -3.69% 59 ROC % is -46.75% as of Dec. 2025. GuruFocus rates TPE:6550 with a GF Score™ of 59/100 and a GF Value™ of NT$55.10 (Possible Value Trap). The stock has 6 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Polaris Group's annualized return on capital (ROC %) for the quarter that ended in Dec. 2025 was -46.75%.

As of today (2026-06-26), Polaris Group's WACC % is -0.96%. Polaris Group's ROC % is -47.06% (calculated using TTM income statement data). Polaris Group earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Polaris Group  (TPE:6550) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Polaris Group's WACC % is -0.96%. Polaris Group's ROC % is -47.06% (calculated using TTM income statement data). Polaris Group earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Polaris Group ROC % Related Terms


Polaris Group ROC % Historical Data

* Premium members only.

The historical data trend for Polaris Group's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polaris Group ROC % Chart

Polaris Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -42.92 -64.85 -56.33 -49.43 -51.65

Polaris Group Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.77 -46.16 -48.05 -43.44 -46.75
TPE:6550
59GF Score
Polaris Group TPE:6550
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polaris Group ROC % Calculation

Polaris Group's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=-2878.711 * ( 1 - 0% )/( (5871.873 + 5274.657)/ 2 )
=-2878.711/5573.265
=-51.65 %

where

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9090.44 - 362.313 - ( 3123.353 - max(0, 468.894 - 3325.148+3123.353))
=5871.873

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8167.929 - 461.779 - ( 2743.4 - max(0, 585.86 - 3017.353+2743.4))
=5274.657

Polaris Group's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-2928.184 * ( 1 - 0% )/( (7251.879 + 5274.657)/ 2 )
=-2928.184/6263.268
=-46.75 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8180.384 - 389.682 - ( 2071.152 - max(0, 1805.099 - 2343.922+2071.152))
=7251.879

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8167.929 - 461.779 - ( 2743.4 - max(0, 585.86 - 3017.353+2743.4))
=5274.657

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -46.75% mean?
Polaris Group (TPE:6550) has a ROC % of -46.75% as of Dec. 2025. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Polaris Group and its competitors.
Is Polaris Group's ROC % too high?
Polaris Group's current ROC % is -46.75%. Overall, Polaris Group has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polaris Group's ROC % compare to VRTX and REGN?
Polaris Group's ROC % of -46.75% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Biotechnology company?
A good ROC % depends on the Biotechnology industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Polaris Group and its competitors. Polaris Group's current ROC % is -46.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polaris Group stock overvalued right now?
Based on GuruFocus' analysis, Polaris Group (TPE:6550) is currently considered Possible Value Trap. The stock's GF Value™ is NT$55.10, compared to a current price of NT$13.05 — trading 76.3% below its estimated fair value. The current ROC % is -46.75%. Polaris Group's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Polaris Group (TPE:6550), the current ROC % is -46.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Polaris Group (TPE:6550) Overvalued in 2026?

Based on GuruFocus' analysis, Polaris Group stock appears to be undervalued. The current stock price of NT$13.05 is trading 76.3% below its estimated GF Value™ of NT$55.10. GuruFocus considers Polaris Group to be Possible Value Trap.

Key valuation signals for TPE:6550:

  • ROC %: -46.75%
  • GF Value™: NT$55.10 vs. price of NT$13.05 (76.3% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the TPE:6550 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Polaris Group Business Description

Address Ugland House, PO Box 309, Grand Cayman, CYM, KY1-1104
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.
59GF Score

Get the complete analysis for TPE:6550

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.05
Price
NT$55.10
GF Value